SCHEMBL2918205

SCHEMBL2918205

COc1ccc(-n2nc(C(=O)N3CCCCC3)cc2-c2ccccn2)nn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.41
ADORA2A P29274 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 3/20 0.40
ABL1 P00519 1/20 0.40
BCR P11274 1/20 0.40
CFTR P13569 1/20 0.40
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MALT1 Q9UDY8 1/20 0.39
MGLL Q99685 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
SCD O00767 1/20 0.38
SCD5 Q86SK9 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915785 0.99 ADORA2A (0.42) CYP2C9ADORA2AMEN1KMT2AHPGD
SCHEMBL2919454 0.91 MGLL (0.46) CYP2C9HPGDABL1BCRCFTR
SCHEMBL2921476 0.91 CFTR (0.45) ABL1BCRCFTRALDH1A1MGLL
SCHEMBL2914634 0.91 PTGS2 (0.43) MEN1KMT2AHPGDNPC1ALDH1A1
Hydrochloric Acid SCHEMBL4247447 0.90 MGLL (0.46) CYP2C9HPGDABL1BCRCFTR
SCHEMBL2919430 0.90 MGLL (0.46) MEN1KMT2AHPGDNPC1ALDH1A1
SCHEMBL2917706 0.90 PTGS2 (0.45) ABL1BCRCFTRMGLLL3MBTL1
SCHEMBL5267459 0.90 ALDH1A1 (0.43) MEN1KMT2AHPGDABL1BCR
SCHEMBL2919146 0.90 SCD5 (0.40) MEN1KMT2AHPGDABL1BCR
SCHEMBL2918726 0.90 ABL1 (0.41) CYP2C9MEN1KMT2AHPGDABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1591443-B1 PYRAZOLE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-08-25 EP disclosed
US-7622471-B2 Pyrazole derivatives having a pyridazine and pyridine functionality DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-11-24 US disclosed
US-7622471-B2 Pyrazole derivatives having a pyridazine and pyridine functionality DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-11-24 US disclosed
US-7622471-B2 Pyrazole derivatives having a pyridazine and pyridine functionality DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-11-24 US disclosed
US-20060128685-A1 Pyrazole derivative DAIICHI PHARMACEUTICAL CO., LTD., (JP) 2006-06-15 US disclosed
EP-1591443-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128685-A1 Pyrazole derivative PTGS1, PTGS2, PTGER1 CYP2C9 251/4885ADORA2A 970/4885MEN1 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.